deltatrials
Unknown PHASE4 NCT00775697

Montelukast in Children With Wheezing

Montelukast Effects on Pulmonary Function in Children With Wheezing Aged Less Than 2 Years

Sponsor: Azienda Ospedaliera Universitaria Policlinico

Conditions Wheezing
Interventions Montelukast
Updated 6 times since 2017 Last updated: Jun 18, 2013 Started: Sep 30, 2009 Primary completion: Dec 31, 2013 Completion: Dec 31, 2014

Listed as NCT00775697, this PHASE4 trial focuses on Wheezing and remains ongoing. Sponsored by Azienda Ospedaliera Universitaria Policlinico, it has been updated 6 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE4

  5. Feb 2017 — Jun 2018 [monthly]

    Unknown Status PHASE4

    Status: Enrolling By Invitation → Unknown Status

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Enrolling By Invitation PHASE4

    First recorded

Sep 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Azienda Ospedaliera Universitaria Policlinico
  • Universita di Verona
Data source: Universita di Verona

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Verona, Italy